BlackRock’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
FLAM
DTC
BlackRock's WGS Position: Q2 2026 in Review
BlackRock increased its GeneDx Holdings (WGS) stake by 10% in Q2 2026, buying an estimated $8.84M and bringing the position to 1,706,239 shares worth $117M. The position accounts for ﹤0.01% of the portfolio, ranked #2132.
BlackRock first reported a position in WGS in Q2 2021 and has held it in 21 quarters since. The position peaked at $203M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.
- BlackRock held 1,706,239 shares of GeneDx Holdings worth $117M as of Q2 2026.
- BlackRock bought 155,531 GeneDx Holdings shares in Q2 2026, an estimated $8.84M.
- GeneDx Holdings made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2132 holding.
- BlackRock first reported a position in GeneDx Holdings in Q2 2021 and has held it in 21 quarters since.
- BlackRock's GeneDx Holdings position peaked at $203M in Q4 2025.
- 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.